Brief: Bone Therapeutics Anticipates Cash Runway Until End Of Q1 2022

Biosenic SA

26/10/2021 06:28

Oct 26 (Reuters) - BONE THERAPEUTICS SA  BOTHE.BR :
    * PROVIDES THIRD QUARTER 2021 BUSINESS UPDATE
    * RUNWAY UNTIL END OF Q1 2022 AS DEVELOPMENT OF IMSC
PLATFORM
ACCELERATES
    * FIRST TRANCHE OF EUR 8.0 MILLION OF EIB FINANCING RECEIVED
    * NO STATISTICALLY SIGNIFICANT DIFFERENCE IN KNEE PAIN
REDUCTION
BETWEEN JTA-004, PLACEBO AND ACTIVE COMPARATOR, 3 MONTHS AFTER
TREATMENT IN PHASE III KNEE OSTEOARTHRITIS STUDY
    * SIGNING OF RESEARCH EVALUATION AGREEMENT WITH IMPLANT
THERAPEUTICS AS WELL AS SCIENTIFIC ADVISORY BOARD APPOINTMENTS
LATEST STEPS IN CREATING NEW IMSC PLATFORM

Source text for Eikon:  ID:nGNE3v1sXr 
Further company coverage:  BOTHE.BR 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))